Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
oxycodone (oxycontin) (12 trials)
simufilam (5 trials)
naltrexone (revia) (2 trials)
pti-125 (4 trials)
188re-pti-6d2 (1 trial)
pti-6d2 (1 trial)
Alzheimer Disease (Phase 2)
Disease (Phase 1)
Melanoma (Phase 1)
Opioid-Related Disorders (Phase 2)
Substance-Related Disorders (Phase 2)
Trials (23 total)
Trial APIs (6 total)